Literature DB >> 25432535

A shower of second hit events as the cause of multifocal renal cell carcinoma in tuberous sclerosis complex.

Magdalena E Tyburczy1, Sergiusz Jozwiak2, Izabela A Malinowska1, Yvonne Chekaluk1, Trevor J Pugh3, Chin-Lee Wu4, Robert L Nussbaum5, Sara Seepo6, Tomasz Dzik2, Katarzyna Kotulska2, David J Kwiatkowski7.   

Abstract

Tuberous sclerosis complex (TSC) is a genetic disorder characterized by seizures and tumor formation in multiple organs, mainly in the brain, skin, kidney, lung and heart. Renal cell carcinoma (RCC) occurs in ∼3% of TSC patients, and typically develops at age <50. Here we describe genetic findings in two TSC patients with multiple renal tumors, each of whom had the germline mutation TSC2 p.R905Q. The first (female) TSC patient had a left followed by a right nephrectomy at ages 24 and 27. Both kidneys showed multifocal TSC-associated papillary RCC (PRCC). Targeted, next-generation sequencing (NGS) analysis of TSC2 in five tumors (four from the left kidney, one from the right) showed loss of heterozygosity in one tumor, and four different TSC2 point mutations (p.E1351*, p.R1032*, p.R1713H, c.4178_4179delCT) in the other four samples. Only one of the 11 other tumors available from this patient had one of the TSC2 second hit mutations identified. Whole-exome analysis of the five tumors identified a very small number of additional mutated genes, with an average of 3.4 nonsilent coding, somatic mutations per tumor, none of which were seen in >1 tumor. The second (male) TSC patient had bilateral partial nephrectomies (both at age 36), with similar findings of multifocal PRCC. NGS analysis of TSC2 in two of these tumors identified a second hit mutation c.2355+1G>T in one sample that was not seen in other tumors. In conclusion, we report the first detailed genetic analysis of RCCs in TSC patients. Molecular studies indicate that tumors developed independently due to various second hit events, suggesting that these patients experienced a 'shower' of second hit mutations in TSC2 during kidney development leading to this severe phenotype.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25432535      PMCID: PMC4355019          DOI: 10.1093/hmg/ddu597

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  35 in total

Review 1.  Malignant renal tumors in tuberous sclerosis.

Authors:  R Washecka; M Hanna
Journal:  Urology       Date:  1991-04       Impact factor: 2.649

2.  The somatic genomic landscape of chromophobe renal cell carcinoma.

Authors:  Caleb F Davis; Christopher J Ricketts; Min Wang; Lixing Yang; Andrew D Cherniack; Hui Shen; Christian Buhay; Hyojin Kang; Sang Cheol Kim; Catherine C Fahey; Kathryn E Hacker; Gyan Bhanot; Dmitry A Gordenin; Andy Chu; Preethi H Gunaratne; Michael Biehl; Sahil Seth; Benny A Kaipparettu; Christopher A Bristow; Lawrence A Donehower; Eric M Wallen; Angela B Smith; Satish K Tickoo; Pheroze Tamboli; Victor Reuter; Laura S Schmidt; James J Hsieh; Toni K Choueiri; A Ari Hakimi; Lynda Chin; Matthew Meyerson; Raju Kucherlapati; Woong-Yang Park; A Gordon Robertson; Peter W Laird; Elizabeth P Henske; David J Kwiatkowski; Peter J Park; Margaret Morgan; Brian Shuch; Donna Muzny; David A Wheeler; W Marston Linehan; Richard A Gibbs; W Kimryn Rathmell; Chad J Creighton
Journal:  Cancer Cell       Date:  2014-08-21       Impact factor: 31.743

3.  MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression array.

Authors:  Laurence Albiges; Justine Guegan; Audrey Le Formal; Virginie Verkarre; Nathalie Rioux-Leclercq; Mathilde Sibony; Jean-Christophe Bernhard; Philippe Camparo; Zahira Merabet; Vincent Molinie; Yves Allory; Cedric Orear; Sophie Couvé; Sophie Gad; Jean-Jacques Patard; Bernard Escudier
Journal:  Clin Cancer Res       Date:  2014-03-21       Impact factor: 12.531

Review 4.  Renal cell carcinoma in patients with tuberous sclerosis.

Authors:  M E Weinblatt; E Kahn; J Kochen
Journal:  Pediatrics       Date:  1987-12       Impact factor: 7.124

5.  Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations.

Authors:  Iiro Eerola; Laurence M Boon; John B Mulliken; Patricia E Burrows; Anne Dompmartin; Shoji Watanabe; Romain Vanwijck; Miikka Vikkula
Journal:  Am J Hum Genet       Date:  2003-11-24       Impact factor: 11.025

6.  Renal angiomyolipoma associated with lymph node involvement and renal cell carcinoma in patients with tuberous sclerosis.

Authors:  R S Taylor; D B Joseph; E C Kohaut; E R Wilson; A J Bueschen
Journal:  J Urol       Date:  1989-04       Impact factor: 7.450

7.  Multifocal renal cell carcinoma in sibs from a chromosome 9 linked (TSC1) tuberous sclerosis family.

Authors:  J R Sampson; A Patel; A D Mee
Journal:  J Med Genet       Date:  1995-11       Impact factor: 6.318

Review 8.  Succinate dehydrogenase and human diseases: new insights into a well-known enzyme.

Authors:  Pierre Rustin; Arnold Munnich; Agnès Rötig
Journal:  Eur J Hum Genet       Date:  2002-05       Impact factor: 4.246

9.  Renal cell carcinoma in tuberous sclerosis complex.

Authors:  Ping Yang; Kristine M Cornejo; Peter M Sadow; Liang Cheng; Mingsheng Wang; Yu Xiao; Zhong Jiang; Esther Oliva; Sergiusz Jozwiak; Robert L Nussbaum; Adam S Feldman; Elahna Paul; Elizabeth A Thiele; Jane J Yu; Elizabeth P Henske; David J Kwiatkowski; Robert H Young; Chin-Lee Wu
Journal:  Am J Surg Pathol       Date:  2014-07       Impact factor: 6.394

10.  Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex.

Authors:  Magdalena E Tyburczy; Ji-An Wang; Shaowei Li; Rajesh Thangapazham; Yvonne Chekaluk; Joel Moss; David J Kwiatkowski; Thomas N Darling
Journal:  Hum Mol Genet       Date:  2013-11-23       Impact factor: 6.150

View more
  23 in total

Review 1.  Pancreatic PEComa is a novel member of the family of tuberous sclerosis complex-associated tumors: case report and review of the literature.

Authors:  Christopher P Hartley; David J Kwiatkowski; Lana Hamieh; Joel A Lefferts; Kerrington D Smith; Mikhail Lisovsky
Journal:  Virchows Arch       Date:  2016-10-18       Impact factor: 4.064

Review 2.  New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex.

Authors:  Hilaire C Lam; Julie Nijmeh; Elizabeth P Henske
Journal:  J Pathol       Date:  2016-11-29       Impact factor: 7.996

Review 3.  Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients.

Authors:  S Brakemeier; F Bachmann; K Budde
Journal:  Pediatr Nephrol       Date:  2016-09-01       Impact factor: 3.714

Review 4.  Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies.

Authors:  Kim M Keppler-Noreuil; Victoria E R Parker; Thomas N Darling; Julian A Martinez-Agosto
Journal:  Am J Med Genet C Semin Med Genet       Date:  2016-11-18       Impact factor: 3.908

5.  Potential Pitfalls in Pre-implantation Genetic Diagnosis in a Patient with Tuberous Sclerosis and Isolated Mosaicism for a TSC2 Variant in Renal Tissue.

Authors:  Kristin M Ikeda; Andrew A House; Dervla M Connaughton; Stephen E Pautler; Victoria Mok Siu; Michelle-Lee Jones
Journal:  Mol Syndromol       Date:  2021-03-09

6.  BHD-associated kidney cancer exhibits unique molecular characteristics and a wide variety of variants in chromatin remodeling genes.

Authors:  Hisashi Hasumi; Mitsuko Furuya; Kenji Tatsuno; Shogo Yamamoto; Masaya Baba; Yukiko Hasumi; Yasuhiro Isono; Kae Suzuki; Ryosuke Jikuya; Shinji Otake; Kentaro Muraoka; Kimito Osaka; Narihiko Hayashi; Kazuhide Makiyama; Yasuhide Miyoshi; Keiichi Kondo; Noboru Nakaigawa; Takashi Kawahara; Koji Izumi; Junichi Teranishi; Yasushi Yumura; Hiroji Uemura; Yoji Nagashima; Adam R Metwalli; Laura S Schmidt; Hiroyuki Aburatani; W Marston Linehan; Masahiro Yao
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

7.  Somatic Mutations Activating the mTOR Pathway in Dorsal Telencephalic Progenitors Cause a Continuum of Cortical Dysplasias.

Authors:  Alissa M D'Gama; Mollie B Woodworth; Amer A Hossain; Sara Bizzotto; Nicole E Hatem; Christopher M LaCoursiere; Imad Najm; Zhong Ying; Edward Yang; A James Barkovich; David J Kwiatkowski; Harry V Vinters; Joseph R Madsen; Gary W Mathern; Ingmar Blümcke; Annapurna Poduri; Christopher A Walsh
Journal:  Cell Rep       Date:  2017-12-26       Impact factor: 9.423

8.  Genomic and Pathological Characterization of Multiple Renal Cell Carcinoma Regions in Patient With Tuberous Sclerosis Complex: A Case Report.

Authors:  Tetsuya Yamamoto; Taigo Kato; Koji Hatano; Atsunari Kawashima; Takeshi Ujike; Shinichiro Fukuhara; Hiroshi Kiuchi; Ryoichi Imamura; Naokazu Ibuki; Kazuma Kiyotani; Masako Kurashige; Eichi Morii; Kazutoshi Fujita; Norio Nonomura; Motohide Uemura
Journal:  Front Oncol       Date:  2021-05-12       Impact factor: 6.244

Review 9.  Precision Therapy for Epilepsy Related to Brain Malformations.

Authors:  Alissa M D'Gama; Annapurna Poduri
Journal:  Neurotherapeutics       Date:  2021-10-04       Impact factor: 6.088

Review 10.  Renal tumors in tuberous sclerosis complex.

Authors:  Peter Trnka; Sean E Kennedy
Journal:  Pediatr Nephrol       Date:  2020-10-01       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.